Clinical Trial Update: Neural Conduction Along the Visual Pathways After Oral Treatment With Citicoline in Patients With Optic Nerve Diseases [Phase 4]

View source ↗

Summary

Phase 4 trial investigating oral citicoline effects on neural conduction along visual pathways in patients with optic nerve diseases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Optic Neuropathy Ischemic

Drugs mentioned

• Citicoline (CDP-choline)

Snippet

Sponsor: Fondazione G.B. Bietti, IRCCS | Conditions: Glaucoma, Optic Neuropathy, Ischemic | Phase 4 | Status: COMPLETED